Raymond James & Associates Spdr Ser Tr Spdr S&P Biotech E Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Raymond James & Associates holds 383,355 shares of XBI stock, worth $33 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

383,355

Previous 355,844 7.73%

Holding current value

$33 Million

Previous $33 Million 14.81%

% of portfolio

0.02%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$90.87 - $102.43 $2.5 Million - $2.82 Million	27,511 Added 7.73%	383,355 $37.9 Million
Q2 2024 Jul 19, 2024	SELL	$82.22 - $94.12 $5.17 Million - $5.92 Million	-62,860 Reduced 15.01%	355,844 $33 Million
Q1 2024 Apr 22, 2024	BUY	$87.05 - $102.89 $8.97 Million - $10.6 Million	103,077 Added 32.66%	418,704 $39.7 Million
Q4 2023 Jan 16, 2024	BUY	$64.12 - $90.86 $1.66 Million - $2.35 Million	25,856 Added 8.92%	315,627 $28.2 Million
Q3 2023 Oct 24, 2023	SELL	$71.88 - $85.76 $1.08 Million - $1.29 Million	-15,091 Reduced 4.95%	289,771 $21.2 Million
Q2 2023 Jul 25, 2023	SELL	$75.38 - $90.23 $1.41 Million - $1.69 Million	-18,711 Reduced 5.78%	304,862 $25.4 Million
Q1 2023 Apr 14, 2023	SELL	$73.13 - $91.97 $1.47 Million - $1.84 Million	-20,042 Reduced 5.83%	323,573 $24.7 Million
Q4 2022 Feb 08, 2023	BUY	$76.72 - $85.66 $4.12 Million - $4.6 Million	53,758 Added 18.55%	343,615 $28.5 Million
Q3 2022 Oct 25, 2022	BUY	$75.06 - $94.9 $2.23 Million - $2.82 Million	29,748 Added 11.44%	289,857 $23 Million
Q2 2022 Aug 12, 2022	BUY	$62.81 - $96.09 $4.32 Million - $6.61 Million	68,837 Added 35.99%	260,109 $19.3 Million
Q1 2022 May 11, 2022	SELL	$81.07 - $115.44 $1.36 Million - $1.94 Million	-16,805 Reduced 8.08%	191,272 $17.2 Million
Q4 2021 Feb 08, 2022	BUY	$108.77 - $134.15 $1.86 Million - $2.29 Million	17,085 Added 8.95%	208,077 $23.3 Million
Q3 2021 Nov 02, 2021	SELL	$118.69 - $138.49 $1.43 Million - $1.67 Million	-12,058 Reduced 5.94%	190,992 $24 Million
Q2 2021 Aug 11, 2021	SELL	$122.48 - $139.69 $1.85 Million - $2.1 Million	-15,068 Reduced 6.91%	203,050 $27.5 Million
Q1 2021 May 14, 2021	BUY	$129.36 - $173.99 $542,277 - $729,366	4,192 Added 1.96%	218,118 $29.6 Million
Q4 2020 Feb 12, 2021	SELL	$110.36 - $151.14 $3.69 Million - $5.05 Million	-33,410 Reduced 13.51%	213,926 $30.1 Million
Q3 2020 Nov 04, 2020	SELL	$103.87 - $120.36 $1.33 Million - $1.54 Million	-12,799 Reduced 4.92%	247,336 $27.6 Million
Q2 2020 Jul 28, 2020	BUY	$73.26 - $114.17 $2.32 Million - $3.62 Million	31,704 Added 13.88%	260,135 $29.1 Million
Q1 2020 Apr 21, 2020	SELL	$65.95 - $98.35 $1.22 Million - $1.83 Million	-18,567 Reduced 7.52%	228,431 $17.7 Million
Q4 2019 Feb 12, 2020	BUY	$74.65 - $98.46 $431,327 - $568,901	5,778 Added 2.4%	246,998 $23.5 Million
Q3 2019 Nov 07, 2019	SELL	$76.25 - $83.86 $5.38 Million - $5.92 Million	-70,613 Reduced 22.64%	241,220 $18.4 Million
Q2 2019 Aug 06, 2019	SELL	N/A	-18,735 Reduced 5.67%	311,833 $27.4 Million
Q1 2019 May 06, 2019	SELL	N/A	-1,583 Reduced 0.48%	330,568 $29.9 Million
Q4 2018 Feb 11, 2019	SELL	N/A	-152,969 Reduced 31.53%	332,151 $23.8 Million
Q3 2018 Nov 14, 2018	BUY	N/A	52,868 Added 12.23%	485,120 $46.5 Million
Q2 2018 Aug 14, 2018	SELL	N/A	-2,905 Reduced 0.67%	432,252 $41.1 Million
Q1 2018 May 14, 2018	SELL	N/A	-10,322 Reduced 2.32%	435,157 $38.2 Million
Q4 2017 Feb 14, 2018	BUY	N/A	93,802 Added 26.67%	445,479 $37.8 Million
Q3 2017 Nov 13, 2017	BUY	N/A	48,631 Added 16.05%	351,677 $30.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	303,046	303,046 $23.4 Million

Others Institutions Holding XBI

# of Institutions

916

Shares Held

102M

Call Options Held

27.4M

Put Options Held

38.6M

View Full List

About SPDR SER TR SPDR S&P BIOTECH E

Ticker XBI
Sector ETFs
Industry ETFs

More about XBI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Spdr Ser Tr Spdr S&P Biotech E Transaction History